Product Information
INDOMETHACIN 25 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0934 per EA under NDC 68462040601. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462040601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
INDOMETHACINApproval Type
Generic (ANDA)
FDA Application
ANDA091276FDA Approved
12/22/2010
TE Code
AB
On Market Since
12/22/2010
Pharmacological Classes
Price Statistics
The NADAC for INDOMETHACIN 25 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0934 per EA |
|---|---|
| All-time high | $0.1430 (Oct 15, 2014) |
| All-time low | $0.0869 (Dec 19, 2018) |
| 52-week high | $0.1086 |
| 52-week low | $0.0917 |
| Median price | $0.1091 |
| Average price | $0.1102 |
| Largest weekly change | +42.7% (May 18, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Indomethacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INDOMETHACIN 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INDOMETHACIN 25 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0934 per EA (NDC 68462040601), effective Sep 30, 2026.
How has the price of INDOMETHACIN 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INDOMETHACIN 25 MG CAPSULE has declined 28.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INDOMETHACIN 25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for INDOMETHACIN 25 MG CAPSULE has ranged from a low of $0.0869 (Dec 19, 2018) to a high of $0.1430 (Oct 15, 2014), with a median of $0.1091 per EA.
Are there cheaper alternatives to INDOMETHACIN 25 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INDOMETHACIN 25 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures INDOMETHACIN 25 MG CAPSULE?
INDOMETHACIN 25 MG CAPSULE (NDC 68462040601) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.